Quantum-enhanced capture of photons using optical ratchet states

Natural and artificial light harvesting systems often operate in a regime where the flux of photons is relatively low. Besides absorbing as many photons as possible it is therefore paramount to prevent excitons from annihilation via photon re-emission until they have undergone an irreversible energy conversion process. Taking inspiration from photosynthetic antenna structures, we here consider ring-like systems and introduce a class of states we call ratchets: excited states capable of absorbing but not emitting light. This allows our antennae to absorb further photons whilst retaining the excitations from those that have already been captured. Simulations for a ring of four sites reveal a peak power enhancement by up to a factor of 35 under ambient conditions owing to a combination of ratcheting and the prevention of emission through dark-state population. In the slow extraction limit the achievable power enhancement due to ratcheting alone exceeds 20%.Comment: major revision with improved model (all data and figures updated

Solar energy conversion

If solar energy is to become a practical alternative to fossil fuels, we must have efficient ways to convert photons into electricity, fuel, and heat. The need for better conversion technologies is a driving force behind many recent developments in biology, materials, and especially nanoscience

Theory and simulation of quantum photovoltaic devices based on the non-equilibrium Green's function formalism

This article reviews the application of the non-equilibrium Green's function formalism to the simulation of novel photovoltaic devices utilizing quantum confinement effects in low dimensional absorber structures. It covers well-known aspects of the fundamental NEGF theory for a system of interacting electrons, photons and phonons with relevance for the simulation of optoelectronic devices and introduces at the same time new approaches to the theoretical description of the elementary processes of photovoltaic device operation, such as photogeneration via coherent excitonic absorption, phonon-mediated indirect optical transitions or non-radiative recombination via defect states. While the description of the theoretical framework is kept as general as possible, two specific prototypical quantum photovoltaic devices, a single quantum well photodiode and a silicon-oxide based superlattice absorber, are used to illustrated the kind of unique insight that numerical simulations based on the theory are able to provide.Comment: 20 pages, 10 figures; invited review pape

Male factors determining the outcome of intracytoplasmic sperm injection with epididymal and testicular spermatozoa

Summary. During a period of 8 years, 1079 intracytoplasmic sperm injection (ICSI) procedures with aspirated epididymal or testicular spermatozoa were performed. Epididymal spermatozoa were used in 172 cycles and testicular spermatozoa or spermatids in 907 cycles. Multiple biopsies were obtained from at least two different locations in the testes. Retrieved spermatozoa were used after cryopreservation (frozen) or immediately after aspiration (fresh). Three hundred patients had obstructive azoospermia (OA) or ejaculation failure. In 414 cases, azoospermia was caused by impaired spermatogenesis resulting from maldescended testes, chemotherapy/radiotherapy, or by Sertoli-cellonly syndrome, genetic disorders or unknown aetiology. Transfer rates, pregnancy rates and birth rates per ICSI cycle showed no statistically significant differences between testicular and epididymal spermatozoa in men with OA (28% average birth rates in both cases). However, birth rates differed significantly with regard to the status of spermatogenesis. Treatment of men with nonobstructive azoospermia (NOA) resulted in a birth rate of 19% per cycle. In all patient groups, there was no difference in the birth rates achieved with fresh and cryopreserved spermatozoa. While testicular volume, follicle-stimulating hormone level and age of the male patient are no statistically significant prognostic factors, the underlying cause of azoospermia is the most important factor determining the outcome of ICSI with epididymal and testicular spermatozoa. The pregnancy rate is lower in NOA patients than in those with OA

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes

Background: Despite advancements in the treatment of primary and metastatic breast cancer, many patients lack a durable response to these treatments. Patients with triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2(HER2)-positive breast cancer who do not have a pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) have a very poor prognosis. Tumor-infiltrating lymphocytes (TILs) have been identified as a predictive marker for pCR after NACT in TNBC and HER2-positive breast cancer. These patient populations could also be suitable for novel treatment strategies including neoepitope-based therapies. This work analyses the effect of TILs on the pCR in neoadjuvantly treated patients in the TILGen study and presents the procedures aimed at establishing neoepitope-based therapies in this study. Methods: Neoadjuvantly treated HER2-positive and TNBC patients were eligible for the presented analysis concerning the association between TILs and pCR. A total of 146 patients could be identified within the TILGen study. TILs were evaluated as percentage of stromal tumor tissue in core biopsies at primary diagnosis. The phenotype ‘lymphocyte-predominant breast cancer' (LPBC) was associated with pCR by logistic regression adjusted for estrogen receptor status, progesterone receptor status, HER2 status, age at diagnosis, and grading. Results: LPBC was seen in 24 (16.4%) patients. In this patient group, 66.7% achieved a pCR, while the pCR rate was 32.8% in patients with a low TIL count. The adjusted odds ratio was 6.60 (95% confidence interval 2.02-21.56; p < 0.01). Conclusion: TILs are a strong predictor of pCR in TNBC and HER2-positive breast cancer patients. Implications for the use of this information including the effect on prognosis might help to identify patients most likely to benefit from a neoepitope-based therapy approach

Photochemical Charge Separation in Poly(3-hexylthiophene) (P3HT) Films Observed with Surface Photovoltage Spectroscopy

Surface photovoltage spectroscopy (SPS) was used to probe photon induced charge separation in thin films of regioregular and regiorandom poly(3-hexylthiophene) (P3HT) as a function of excitation energy. Both positive and negative photovoltage signals were observed under sub-band-gap (&lt;2.0 eV) and super-band-gap (&gt;2.0 eV) excitation of the polymer. The dependence of the spectra on substrate work function, thermal annealing, film thickness, and illumination intensity was investigated, allowing the identification of interface, charge transfer (CT), and band-gap states in the amorphous and crystalline regions of the polymer films. The ability to probe these states in polymer films will aid the development and optimization of organic electronic devices such as photovoltaics (OPVs), light-emitting diodes (OLEDs), and field effect transistors (OFETs). The direction and size of the observed photovoltage features can be explained using the depleted semiconductor model. © 2013 American Chemical Society

Roadmap on organic inorganic hybrid perovskite semiconductors and devices

Metal halide perovskites are the first solution processed semiconductors that can compete in their functionality with conventional semiconductors, such as silicon. Over the past several years, perovskite semiconductors have reported breakthroughs in various optoelectronic devices, such as solar cells, photodetectors, light emitting and memory devices, and so on. Until now, perovskite semiconductors face challenges regarding their stability, reproducibility, and toxicity. In this Roadmap, we combine the expertise of chemistry, physics, and device engineering from leading experts in the perovskite research community to focus on the fundamental material properties, the fabrication methods, characterization and photophysical properties, perovskite devices, and current challenges in this field. We develop a comprehensive overview of the current state of the art and offer readers an informed perspective of where this field is heading and what challenges we have to overcome to get to successful commercializatio

Wie lang ist die Cochlea? - Die klinisch anwendbare Längenmessung der Cochlea

Einleitung: Die Bestimmung der Cochlealänge ist eine zentrale Frage in der Hörforschung und -versorgung. Zahlreiche Arbeiten weisen auf individuelle Unterschiede hin. Wenige Arbeiten beschäftigen sich mit der Messung der tatsächlichen Länge in einer klinisch verfügbaren Bildgebungsmodalität. Ziele: Es soll eine hohe Anzahl an Cochleae in DVT-Datensätzen analysiert werden, um valide Ergebnisse ermitteln zu können.Methodik: Die Felsenbeinbildgebung von vorstelligen Patienten wurde retrospektiv mittels dreidimensionaler multiplanarer Rekonstruktion (3D MPR) in der DVT auf Länge der Cochlea hin ausgewertet. Ergebnisse: Nur Patienten, bei welchen eine Messung beider Ohren möglich war, wurden eingeschlossen (408 Cochleae, hiervon 216 weiblich, 192 männlich, 205 linke, 203 rechte). Die kürzeste Cochlea ist 32 mm und die längste 43,5 mm lang. Es zeigt sich für alle Gruppen eine Normalverteilung. Die mittlere Länge der Cochlea ist beim männlichen Geschlecht 38 mm und beim weiblichen 37,2 mm (t-Test: p<0,0001). Die mittlere Länge der linken Cochlea ist 37,5 mm sowie 37,7 mm für die rechte (t-Test: p=0,306). Eine Korrelation zum Alter konnte nicht festgestellt werden.Zusammenfassung: Es kann erstmals in einer hohen Anzahl von Patienten die individuelle Cochlealänge in einem ebenso klinisch verfügbaren Datensatz aufgezeigt werden. Die männliche Cochlea ist signifikant länger als die weibliche. Individuelle Unterschiede können in einem klinisch relevanten Rahmen bestimmt werden und so der Elektrodenwahl dienen. Elektrodenwahl in der Cochleaimplantversorgung ist individualisiert möglich.Der Erstautor gibt keinen Interessenkonflikt an